247 related articles for article (PubMed ID: 20708640)
1. Global gene expression changes in type 1 diabetes: insights into autoimmune response in the target organ and in the periphery.
Planas R; Pujol-Borrell R; Vives-Pi M
Immunol Lett; 2010 Oct; 133(2):55-61. PubMed ID: 20708640
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
[TBL] [Abstract][Full Text] [Related]
3. Selective destruction of mouse islet beta cells by human T lymphocytes in a newly-established humanized type 1 diabetic model.
Zhao Y; Guo C; Hwang D; Lin B; Dingeldein M; Mihailescu D; Sam S; Sidhwani S; Zhang Y; Jain S; Skidgel RA; Prabhakar BS; Mazzone T; Holterman MJ
Biochem Biophys Res Commun; 2010 Sep; 399(4):629-36. PubMed ID: 20691153
[TBL] [Abstract][Full Text] [Related]
4. Unexpected functional consequences of xenogeneic transgene expression in beta-cells of NOD mice.
Leiter EH; Reifsnyder P; Driver J; Kamdar S; Choisy-Rossi C; Serreze DV; Hara M; Chervonsky A
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():14-22. PubMed ID: 17919174
[TBL] [Abstract][Full Text] [Related]
5. 'Sensing' autoimmunity in type 1 diabetes.
Tsui H; Razavi R; Chan Y; Yantha J; Dosch HM
Trends Mol Med; 2007 Oct; 13(10):405-13. PubMed ID: 17900987
[TBL] [Abstract][Full Text] [Related]
6. Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity?
Lam-Tse WK; Lernmark A; Drexhage HA
Springer Semin Immunopathol; 2002 Dec; 24(3):297-321. PubMed ID: 12503056
[TBL] [Abstract][Full Text] [Related]
7. Lessons on autoimmune diabetes from animal models.
Yang Y; Santamaria P
Clin Sci (Lond); 2006 Jun; 110(6):627-39. PubMed ID: 16689681
[TBL] [Abstract][Full Text] [Related]
8. Islet glia, neurons, and beta cells.
Tsui H; Winer S; Chan Y; Truong D; Tang L; Yantha J; Paltser G; Dosch HM
Ann N Y Acad Sci; 2008 Dec; 1150():32-42. PubMed ID: 19120264
[TBL] [Abstract][Full Text] [Related]
9. Dynamic interaction between T cell-mediated beta-cell damage and beta-cell repair in the run up to autoimmune diabetes of the NOD mouse.
Vukkadapu SS; Belli JM; Ishii K; Jegga AG; Hutton JJ; Aronow BJ; Katz JD
Physiol Genomics; 2005 Apr; 21(2):201-11. PubMed ID: 15671250
[TBL] [Abstract][Full Text] [Related]
10. Specific gene expression signature associated with development of autoimmune type-I diabetes using whole-blood microarray analysis.
Reynier F; Pachot A; Paye M; Xu Q; Turrel-Davin F; Petit F; Hot A; Auffray C; Bendelac N; Nicolino M; Mougin B; Thivolet C
Genes Immun; 2010 Apr; 11(3):269-78. PubMed ID: 20090770
[TBL] [Abstract][Full Text] [Related]
11. Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes.
Shieh SJ; Chou FC; Yu PN; Lin WC; Chang DM; Roffler SR; Sytwu HK
J Immunol; 2009 Aug; 183(4):2277-85. PubMed ID: 19635924
[TBL] [Abstract][Full Text] [Related]
12. Dysrulation of T cell peripheral tolerance in type 1 diabetes.
Tisch R; Wang B
Adv Immunol; 2008; 100():125-49. PubMed ID: 19111165
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
[TBL] [Abstract][Full Text] [Related]
14. Early suppression of immune response pathways characterizes children with prediabetes in genome-wide gene expression profiling.
Elo LL; Mykkänen J; Nikula T; Järvenpää H; Simell S; Aittokallio T; Hyöty H; Ilonen J; Veijola R; Simell T; Knip M; Simell O; Lahesmaa R
J Autoimmun; 2010 Aug; 35(1):70-6. PubMed ID: 20356713
[TBL] [Abstract][Full Text] [Related]
15. Heightened interferon-alpha/beta response causes myeloid cell dysfunction and promotes T1D pathogenesis in NOD mice.
Peng RH; Paek E; Xia CQ; Tennyson N; Clare-Salzler MJ
Ann N Y Acad Sci; 2006 Oct; 1079():99-102. PubMed ID: 17130537
[TBL] [Abstract][Full Text] [Related]
16. Contribution of T cells to the development of autoimmune diabetes in the NOD mouse model.
Toyoda H; Formby B
Bioessays; 1998 Sep; 20(9):750-7. PubMed ID: 9819564
[TBL] [Abstract][Full Text] [Related]
17. Immunological aspects of 'fulminant type 1 diabetes'.
Nagata M; Moriyama H; Kotani R; Yasuda H; Kishi M; Kurohara M; Hara K; Yokono K
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S99-103. PubMed ID: 17478003
[TBL] [Abstract][Full Text] [Related]
18. The targeting of β-cells by T lymphocytes in human type 1 diabetes: clinical perspectives.
Luce S; Briet C; Bécourt C; Lemonnier F; Boitard C
Diabetes Obes Metab; 2013 Sep; 15 Suppl 3():89-97. PubMed ID: 24003925
[TBL] [Abstract][Full Text] [Related]
19. CD8+ T cells in type 1 diabetes.
Tsai S; Shameli A; Santamaria P
Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164
[TBL] [Abstract][Full Text] [Related]
20. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
Goldrath AW; Barber L; Chen KE; Alters SE
J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
